Investigating the effectiveness of mindfulness meditation and clinical hypnosis for injury-related pain management in competitive athletes: A replicated single-case experimental desig

Not Applicable

• Conditions: Pain, Acute; Injuries and Accidents - Other injuries and accidents

• Registration Number: ACTRN12624000407594
• Lead Sponsor: The University of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2024-04-03
• Last Update Posted: 8 April 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 18

Inclusion Criteria

a) be a competitive athlete (i.e., compete at a level beyond recreational or casual participation. This includes athletes who participate in regional, national, or international competitions, and those who are members of competitive teams or clubs),
b) currently have a sport or exercise-related injury that resulted in an average pain
intensity greater than or equal to 3 on a 0-10 numerical rating scale in the past
week, and for which the predicted recovery time at the point of study enrolment is
greater than 5 weeks
c) be 18 years of age or over,
d) read, speak, and understand the English language,
e) have access to the internet on a computer or smartphone,
f) have access to a set of earphones,
g) be willing to be randomly assigned to both conditions and listen to five 20-minute treatment sessions (one per day),
h) be willing to participate in a brief daily survey for 25 consecutive days.

Exclusion Criteria

a) Current alcohol or substance dependence;
b) Pain condition for which surgery has been recommended and is planned;
c) Current or past participation in a research study with treatment components that may overlap those in the current study;
d) Current or history of diagnosis of primary psychotic or major thought disorder within the past 5 years;
e) Psychiatric hospitalization within the past 6 months;
f) Psychiatric or behavioural conditions in which symptoms were unstable or severe within the past 6 months;
g) Active malignancy (e.g., cancer not in remission), terminal illnesses, or serious medical conditions that may interfere with either study participation or with receiving potential treatment benefits (e.g., severe lupus).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain intensity[Numerical Rating Scale (NRS) of Current Pain Intensity Assessed daily during the randomised baseline period (5-15 days), during treatment (5 days), and in the randomised maintenance phase (5-15 days).];Pain Unpleasantness[Numerical Rating Scale (NRS) of Current Pain Unpleasantness Assessed daily during the randomised baseline period (5-15 days), during treatment (5 days), and in the randomised maintenance phase (5-15 days).]